Edition:
United States

Marinus Pharmaceuticals Inc (MRNS.OQ)

MRNS.OQ on NASDAQ Stock Exchange Global Market

5.72USD
19 Oct 2018
Change (% chg)

$-0.18 (-3.05%)
Prev Close
$5.90
Open
$5.95
Day's High
$6.02
Day's Low
$5.64
Volume
101,914
Avg. Vol
195,277
52-wk High
$10.54
52-wk Low
$3.31

Chart for

About

Marinus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders. Its clinical-stage product candidate, ganaxolone, is a modulator being developed in various dose forms, including intravenous, oral... (more)

Overall

Beta: 2.69
Market Cap(Mil.): $298.67
Shares Outstanding(Mil.): 40.53
Dividend: --
Yield (%): --

Financials

  MRNS.OQ Industry Sector
P/E (TTM): -- 29.75 32.14
EPS (TTM): -0.73 -- --
ROI: -79.32 13.18 12.83
ROE: -79.63 15.14 14.95

Earnings vs. Estimates